Last updated: May 10, 2023
Sponsor: Universitair Ziekenhuis Brussel
Overall Status: Active - Recruiting
Phase
4
Condition
Lymphedema
Treatment
Local Injection Anesthesia
SAPB
Clinical Study ID
NCT04756791
SAPLIA
Ages 18-80 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age 18-80 years.
- Provision of signed informed consent prior to any study-specific procedure.
- Patients who come to preoperative anesthesia consultation for their scheduledunilat-eral mastectomy.
Exclusion
Exclusion Criteria:
- Age >80 years
- History of chronic pain or drug treatment abuse
- Depression, psychiatric morbidity or mal-adaptive coping behavior
- Neuropathy
- Severe anxiety or other mental ailment, taking drugs affecting their capacity toassess pain
- Chronic or acute skin infection of the lateral thorax
- Hypersensitivity to ropivacaine
- Severe hepatic or renal disease
- Refuse to participate to the study
- Pregnancy
Study Design
Total Participants: 68
Treatment Group(s): 2
Primary Treatment: Local Injection Anesthesia
Phase: 4
Study Start date:
June 16, 2021
Estimated Completion Date:
December 31, 2024
Study Description
Connect with a study center
UZ Brussel
Jette, Brussel 1090
BelgiumActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.